Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for energy industry professionals · Wednesday, July 6, 2022 · 579,969,423 Articles · 3+ Million Readers

Nuclear Medicine Market Size Worth USD 13 Billion by 2027 at 13% CAGR - Report by Market Research Future (MRFR)

Nuclear Medicine Market Trends and Insights by Product Type (Diagnostic nuclear medicine and Therapeutic radiopharmaceuticals), Application (Diagnostic applications and Therapeutic applications), End-user (Hospitals & diagnostic centers, Research institutes, and Others), and Region, Competitive Market Growth, Size, Share and Forecast to 2027

/EIN News/ -- New York, USA, June 20, 2022 (GLOBE NEWSWIRE) -- Nuclear Medicine Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Nuclear Medicine Market Information by Product Type, Application, End-User, and Region - Forecast till 2027”, the nuclear medicine market will capture a CAGR of 13% and estimated to touch USD 13 billion by 2027.

Nuclear Medicine Market Synopsis

Nuclear medicine typically deals with the utilization of radioactive substances in diagnosis, treatment, and research. Surging cases of cancer, as well as cardiac ailments worldwide, are fostering the market demand.

Nuclear medicine has the potential to treat cancer and cardiac diseases. The National Cancer Institute reveals that nearly 1,654,130 cases of cancer were recorded in the United States in 2020, giving a push to the use of nuclear medicine. Other factors propelling the market position include the rising PET and SPECT applications along with the mounting public awareness.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/6674

Report Scope:

Report Attribute Details
Market Size USD 13 billion
CAGR 13%
Base Year 2019
Forecast Period 2020-2027
Historical Data 2018
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Product Type, Application, End User
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers Increasing number of cancer cases
Rising awareness about nuclear medicine

Nuclear Medicine Market Competitive Landscape:

The affluent firms in the nuclear medicine market include

  • GE Healthcare
  • Medtronic plc
  • Cardinal Health
  • Bracco Imaging
  • Jubliant Lifesciences
  • Lantheus Medical Imaging
  • Bayer
  • Advanced Accelerators Applications
  • Mallinckrodt Pharmaceuticals
  • Nordion Inc.
  • Curium

Market USP Covered:

Market Drivers:

The worldwide market has been experiencing exponential growth, thanks to the extensive product pipeline and the supportive government initiatives for enhancing access to nuclear medicine. At present, 177Lu-PNT2002, omburtamab, betalutin, PNT2003, and yttrium-90 microspheres are a few of the products that are undergoing clinical trials. The nuclear medicine industry has been moderately affected by SARS-CoV-2. The operation and use of reactors have been classified as critical services, as a result of which, nuclear reactors continued to note high demand despite the SARS-CoV-2 lockdown. To illustrate, under Section 71 of the Labour Act 66 in South Africa, the SAFARI-1 reactor continued being in operation during the lockdown post-March 2020.

The favorable reimbursement scenario with respect to radiopharmaceuticals in various countries, especially the United States will favor the worldwide market. In 2020, USD 10 add-on payment was offered by the Center for Medical Services (CMS) for Tc-99m sourced from non-highly enriched uranium for hospital outpatient service. There was additional payment for advanced imaging procedures. These initiatives resulted in higher patient access to diagnostic nuclear medicines for life-threatening diseases.

Surging innovations in diagnosis as well as treatment of various diseases, and the rise in approvals of nuclear-medicine-based devices for addressing several treatment needs will benefit the worldwide market. To cite a reference, in September 2021, GE Healthcare introduced novel scanner that had an advanced automated workflow feature, which provides an exceptional image of cardiac anatomy as well as pathology to assist physicians in determining the right treatment for the patient.

Market Restraints:

Radiopharmaceuticals have to deal with extra scrutiny and are subject to certain approval and regulatory pathways. In a few cases, toxicology testing can give rise to a substantial financial burden for the testers/investigators. Besides, reimbursement hurdles for manufacturers and the significant capital investments required could restrain the market growth in subsequent years.

However, the escalating use of radiopharmaceuticals in a number of neurologic applications could present lucrative opportunities to the manufacturers in the nuclear medicine market.

COVID 19 Analysis

The COVID-19 outbreak’s significant impact has led to numerous severe repercussions on people’s health status across the world. The aftermath is linked with the significant social and economic burden on people worldwide. While the major policymakers are implementing new frameworks and industries are adopting advanced models of expansion to maintain their relevance, people are facing a series of mental trauma.

Around the world, the rising cases have spurred mental, and economic issues, especially among the elderly. Additionally, the global populace has been dealing with challenges owing to loss of livelihoods and is opting for family care to address the repercussions. The focus is largely on the treatment of COVID-19 and the development of a vaccine, which steers attention away from other markets. These factors will most likely be unfavorable for the nuclear medicine market in the years to come.

Browse In-depth Market Research Report (100 Pages) on Nuclear Medicine: https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674

Nuclear Medicine Market Segmentation

By Product Type

The product types covered in the research study include therapeutic radiopharmaceuticals and diagnostic nuclear medicine. At present, the diagnostic nuclear medicine segment is in the lead while the therapeutic radiopharmaceuticals segment will procure the fastest growth rate between 2020 and 2027. The diagnostics-based segments are SPECT radiopharmaceuticals along with PET radiopharmaceuticals. SPECT radiopharmaceutical types are Tc99m, I-123, and others. PET radiopharmaceuticals-based segments are F18, C11 Choline, and more. 

By Application

Nuclear medicine has applications in diagnostic applications as well as therapeutic applications. Diagnostic application is the top segment in the market, with its sub-segments considered in the report including PET applications coupled with SPECT applications. The therapeutic applications segment could procure the fastest CAHR in the future.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=6674

By End-User

End-users are research institutes, hospitals & diagnostic centres, and more. Research institutes will cover maximum ground in the years to come while the hospitals & diagnostics centres segment will progress at the fastest rate.

Nuclear Medicine Market Regional Insights

Considering the rapid surge in technological advances and the presence of highly advanced medical facilities, the American market is the highest gainer out of all the regions. The regional market is led by the United States, as the country houses some of the most influential companies in the world. These companies spend considerably on extensive R&D activities for new medicines, enhancing the market share.

Share your Queries @ https://www.marketresearchfuture.com/enquiry/6674

Escalating cases of cancer and various chronic disorders should also benefit the American market. Developed nations like Canada and the United States have well-established medical facilities and the growth of the overall healthcare industry is quite rapid. America’s huge geriatric patient pool and the mounting awareness regarding the latest therapies should further elevate the nuclear medicine market position in the region.

Discover more research Reports on Healthcare Industry, by Market Research Future:

Wearable Tracking Devices Market Share, Insights and Growth Analysis by Types (Wrist Wear, Fitness Bands, Foot Wear), Application (Healthcare, Consumer Electronics), Sales Channel (Online, And Offline), End-User (Sports Person, Patients) - Forecast Till 2027

Needle-Free Diabetes Care Market Research Report, By Devices Types (Treatment Devices And Diagnostic Devices), Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, Others), Application (Insulin Delivery And Other), End Users (Diagnostic Centers, Hospitals & Clinics And Other)-Forecast Till 2027

Continuous Positive Airway Pressure (CPAP) Devices Market Information: By Product Type (CPAP Motors, CPAP Hoses, CPAP Mask, others), Features (Humidifier, Portability, Heated Tubing), Automation (Manual, Automatic) & End User (Hospitals, Private Clinics, Home Care) - Forecast till 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter


Market Research Future (Part of Wantstats Research and Media Private Limited)
                    99 Hudson Street, 5Th Floor
                    New York, NY 10013
                    United States of America
                    +1 628 258 0071 (US)
                    +44 2035 002 764 (UK)
                    Email: sales@marketresearchfuture.com
                    Website: https://www.marketresearchfuture.com
                    
Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release